Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melatonin and Parkinson's disease.

Juan C Mayo1, Rosa M Sainz, Dun-Xian Tan

  • 1Departamento de Morfología y Biología Celular, School of Medicine, University of Oviedo, Oviedo, Spain.

Endocrine
|October 12, 2005
PubMed
Summary

Melatonin, a potent antioxidant, shows promise in protecting against Parkinson's disease (PD) neurodegeneration. Its protective mechanisms are being explored as a complementary therapy for PD, a condition marked by dopamine loss and oxidative stress.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engaging Stakeholders to Define Research Priorities and Build a Research Community to Reduce Obesity Among Hispanic Women in the Southeastern United States.

Journal of racial and ethnic health disparities·2026
Same author

Hereditary myopathy with early respiratory failure.

Practical neurology·2025
Same author

"PrevenganT2," a Culturally Responsive Family-Based Diabetes Prevention Intervention for Hispanic or Latino Adults at High Risk for Type 2 Diabetes: Protocol for a Proof-of-Concept Evaluation.

JMIR research protocols·2025
Same author

Evidence of slab tearing on an inherited Mesozoic rift transfer fault in the Betic Cordillera.

Scientific reports·2025
Same author

Cost-Utility Analysis of a Group Mindfulness Program Compared to an Education Support Program for Breast Cancer Survivors With Cognitive Impairment: Evidence From a Randomized Controlled Trial.

Psycho-oncology·2025
Same author

Derivation and Validation of a COPD-specific Pulmonary Embolism Diagnostic Strategy.

Thrombosis and haemostasis·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Parkinson's disease (PD) involves progressive dopamine neuron loss, with significant neuronal death preceding symptoms.
  • Current treatments like levodopa (l-dopa) offer symptomatic relief but can cause long-term pro-oxidant damage.
  • Oxidative stress, free radical generation, and mitochondrial dysfunction are key factors in PD etiology.

Purpose of the Study:

  • To review the neuroprotective effects and mechanisms of melatonin in Parkinson's disease.
  • To explore melatonin as a potential co-treatment alongside traditional PD therapies.

Main Methods:

  • Review of in vivo and in vitro studies investigating melatonin's efficacy in PD models.
  • Analysis of the antioxidant and free radical scavenging actions of melatonin.

Related Experiment Videos

Main Results:

  • Melatonin demonstrates significant neuroprotective properties in experimental models of PD.
  • Its potent antioxidant actions counteract the oxidative stress implicated in PD pathogenesis.

Conclusions:

  • Melatonin's antioxidant capabilities make it a promising therapeutic agent for Parkinson's disease.
  • Further research into melatonin's mechanisms could lead to novel co-treatment strategies for PD.